Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.

Trial Profile

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Imatinib (Primary)
  • Indications Malignant thymoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jan 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Actual end date (1 Mar 2011 ) added as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top